Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023, unless spurred by [...] …
Articles by : Rich Daly, Editor in Chief
The congressional sponsor of legislation that would require hospitals and potentially other covered entities to publicly report their 340B revenue, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The boards of directors of health centers need to take on a bigger advocacy role in support of the 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The nation’s largest hospital advocacy organization urged legislators to drop a provision from draft legislation that would exclude generic injectables [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An alliance led by a powerful drug industry trade group and community health center organization that is pushing for 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Amid nationwide uncertainty over both the legality of the scope of the 340B contract pharmacy program and the legality of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The first posted fiscal year 2023 audit of a drug maker tentatively found the company owes repayments to providers. The [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal officials confirmed that 340B-eligible drugs are among the 12 medications pharmaceutical manufacturer Pfizer has limited to direct purchase after [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three provider organizations may have contract pharmacies terminated from the 340B program and 10 providers would owe repayments to drug [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The hiring of lobbyists in the congressional legislative fight over 340B was dominated by pharmaceutical firms and provider-manufacturer alliances in [...] …
